The CATS (FAM64A) protein is a substrate of the Kinase Interacting Stathmin (KIS)

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1833, Issue 5, 2013, Pages 1269-1279

  Archangelo, Leticia Fröhlich ^a   Greif, Philipp A ^b   Maucuer, Alexandre ^c   Manceau, Valérie ^c   Koneru, Naresh ^b   Bigarella, Carolina L ^a,f   Niemann, Fernanda ^a   dos Santos, Marcos Tadeu ^d,g   Kobarg, Jörg ^d   Bohlander, Stefan K ^b,e   Saad, Sara Teresinha Olalla ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF MUNICH   (Germany)

^c INSTITUT DU FER À MOULIN   (France)

^d BRAZILIAN CENTER FOR RESEARCH IN ENERGY AND MATERIALS CNPEM   (Brazil)

^e PHILIPPS UNIVERSITY MARBURG   (Germany)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g Fleury   (Brazil)

Author keywords

CALM AF10 leukemia; CATS; FAM64A; KIS; Phosphorylation; UHMK1

Indexed keywords

CATS PROTEIN; HYBRID PROTEIN; KINASE INTERACTING STATHMIN PROTEIN; MITOGENIC AGENT; PHOSPHOPROTEIN; STATHMIN; UNCLASSIFIED DRUG;

ANAPHASE; ARTICLE; CANCER CELL CULTURE; CELL DIVISION; CELL PROLIFERATION; CELLULAR DISTRIBUTION; CHROMATIN IMMUNOPRECIPITATION; HUMAN; HUMAN CELL; LEUKEMOGENESIS; METAPHASE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; REPRESSOR GENE;

BINDING SITES; CARRIER PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HUMANS; IMMUNOPRECIPITATION; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; ONCOGENE PROTEINS, FUSION; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION MAPS; PROTEIN-SERINE-THREONINE KINASES;

EID: 84875235882     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2013.02.004     Document Type: Article

References (43)

1. Dreyling M.H., Martinez-Climent J.A., Zheng M., Mao J., Rowley J.D., Bohlander S.K. The t(10;11)(p13;q14) in the U937 cell line results in the fusion of the AF10 gene and CALM, encoding a new member of the AP-3 clathrin assembly protein family. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:4804-4809.
2. Dreyling M.H., Schrader K., Fonatsch C., Schlegelberger B., Haase D., Schoch C., Ludwig W., Loffler H., Buchner T., Wormann B., Hiddemann W., Bohlander S.K. MLL and CALM are fused to AF10 in morphologically distinct subsets of acute leukemia with translocation t(10;11): both rearrangements are associated with a poor prognosis. Blood 1998, 91:4662-4667.
3. Kumon K., Kobayashi H., Maseki N., Sakashita A., Sakurai M., Tanizawa A., Imashuku S., Kaneko Y. Mixed-lineage leukemia with t(10;11)(p13;q21): an analysis of AF10-CALM and CALM-AF10 fusion mRNAs and clinical features. Genes Chromosomes Cancer 1999, 25:33-39.
4. Narita M., Shimizu K., Hayashi Y., Taki T., Taniwaki M., Hosoda F., Kobayashi H., Nakamura H., Sadamori N., Ohnishi H., Bessho F., Yanagisawa M., Ohki M. Consistent detection of CALM-AF10 chimaeric transcripts in haematological malignancies with t(10;11)(p13;q14) and identification of novel transcripts. Br. J. Haematol. 1999, 105:928-937.
5. Asnafi V., Beldjord K., Libura M., Villarese P., Millien C., Ballerini P., Kuhlein E., Lafage-Pochitaloff M., Delabesse E., Bernard O., Macintyre E. Age-related phenotypic and oncogenic differences in T-cell acute lymphoblastic leukemias may reflect thymic atrophy. Blood 2004, 104:4173-4180.
6. Asnafi V., Buzyn A., Thomas X., Huguet F., Vey N., Boiron J.M., Reman O., Cayuela J.M., Lheritier V., Vernant J.P., Fiere D., Macintyre E., Dombret H. Impact of TCR status and genotype on outcome in adult T-cell acute lymphoblastic leukemia: a LALA-94 study. Blood 2005, 105:3072-3078.
7. Asnafi V., Radford-Weiss I., Dastugue N., Bayle C., Leboeuf D., Charrin C., Garand R., Lafage-Pochitaloff M., Delabesse E., Buzyn A., Troussard X., Macintyre E. CALM-AF10 is a common fusion transcript in T-ALL and is specific to the TCRgammadelta lineage. Blood 2003, 102:1000-1006.
8. Deshpande A.J., Cusan M., Rawat V.P., Reuter H., Krause A., Pott C., Quintanilla-Martinez L., Kakadia P., Kuchenbauer F., Ahmed F., Delabesse E., Hahn M., Lichter P., Kneba M., Hiddemann W., Macintyre E., Mecucci C., Ludwig W.D., Humphries R.K., Bohlander S.K., Feuring-Buske M., Buske C. Acute myeloid leukemia is propagated by a leukemic stem cell with lymphoid characteristics in a mouse model of CALM/AF10-positive leukemia. Cancer Cell 2006, 10:363-374.
9. Deshpande A.J., Rouhi A., Lin Y., Stadler C., Greif P., Arseni N., Opatz S., Quintanilla-Fend L., Holzmann K., Hiddemann W., Dohner K., Dohner H., Xu G., Armstrong S.A., Bohlander S.K., Buske C. The clathrin-binding domain of CALM and the OM-LZ domain of AF10 are sufficient to induce acute myeloid leukemia in mice. Leukemia 2011, 25:1718-1727.
10. Caudell D., Zhang Z., Chung Y.J., Aplan P.D. Expression of a CALM-AF10 fusion gene leads to Hoxa cluster overexpression and acute leukemia in transgenic mice. Cancer Res. 2007, 67:8022-8031.
11. Dik W.A., Brahim W., Braun C., Asnafi V., Dastugue N., Bernard O.A., van Dongen J.J., Langerak A.W., Macintyre E.A., Delabesse E. CALM-AF10+ T-ALL expression profiles are characterized by overexpression of HOXA and BMI1 oncogenes. Leukemia 2005, 19:1948-1957.
12. Mulaw M.A., Krause A.J., Deshpande A., Krause L.F., Rouhi A., La Starza R., Borkhardt A., Buske C., Mecucci C., Ludwig W.D., Lottaz C., Bohlander S.K. CALM/AF10-positive leukemias show upregulation of genes involved in chromatin assembly and DNA repair processes and of genes adjacent to the breakpoint at 10p12. Leukemia 2012, 26:1012-1019.
13. Okada Y., Jiang Q., Lemieux M., Jeannotte L., Su L., Zhang Y. Leukaemic transformation by CALM-AF10 involves upregulation of Hoxa5 by hDOT1L. Nat. Cell Biol. 2006, 8:1017-1024.
14. Lin Y.H., Kakadia P.M., Chen Y., Li Y.Q., Deshpande A.J., Buske C., Zhang K.L., Zhang Y., Xu G.L., Bohlander S.K. Global reduction of the epigenetic H3K79 methylation mark and increased chromosomal instability in CALM-AF10-positive leukemias. Blood 2009, 114:651-658.
15. Popp H.D., Bohlander S.K. Genetic instability in inherited and sporadic leukemias. Genes Chromosomes Cancer 2010, 49:1071-1081.
16. Archangelo L.F., Glasner J., Krause A., Bohlander S.K. The novel CALM interactor CATS influences the subcellular localization of the leukemogenic fusion protein CALM/AF10. Oncogene 2006, 25:4099-4109.
17. Greif P.A., Bohlander S.K. Up a lymphoid blind alley: does CALM/AF10 disturb Ikaros during leukemogenesis?. World J. Biol. Chem. 2011, 2:115-118.
18. Greif P.A., Tizazu B., Krause A., Kremmer E., Bohlander S.K. The leukemogenic CALM/AF10 fusion protein alters the subcellular localization of the lymphoid regulator Ikaros. Oncogene 2008, 27:2886-2896.
19. Pasalic Z., Greif P.A., Jurinoviç V., Mulaw M.A., Kakadia P.M., Tizazu B., Archangelo L., Krause A., Bohlander S.K. FHL2 interacts with CALM and is highly expressed in acute erythroid leukemia. Blood Cancer J. 2011, e42. 10.1038/bcj.2011.40.
20. Archangelo L.F., Greif P.A., Holzel M., Harasim T., Kremmer E., Przemeck G.K., Eick D., Deshpande A.J., Buske C., de Angelis M.H., Saad S.T., Bohlander S.K. The CALM and CALM/AF10 interactor CATS is a marker for proliferation. Mol. Oncol. 2008, 2:356-367.
21. Satoh J., Obayashi S., Misawa T., Sumiyoshi K., Oosumi K., Tabunoki H. Protein microarray analysis identifies human cellular prion protein interactors. Neuropathol. Appl. Neurobiol. 2009, 35:16-35.
22. Zhao W.M., Coppinger J.A., Seki A., Cheng X.L., Yates J.R., Fang G. RCS1, a substrate of APC/C, controls the metaphase to anaphase transition. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:13415-13420.
23. Manceau V., Kielkopf C.L., Sobel A., Maucuer A. Different requirements of the kinase and UHM domains of KIS for its nuclear localization and binding to splicing factors. J. Mol. Biol. 2008, 381:748-762.
24. Manceau V., Kremmer E., Nabel E.G., Maucuer A. The protein kinase KIS impacts gene expression during development and fear conditioning in adult mice. PLoS One 2012, 7:e43946.
25. Manceau V., Swenson M., Le Caer J.P., Sobel A., Kielkopf C.L., Maucuer A. Major phosphorylation of SF1 on adjacent Ser-Pro motifs enhances interaction with U2AF65. FEBS J. 2006, 273:577-587.
26. Maucuer A., Ozon S., Manceau V., Gavet O., Lawler S., Curmi P., Sobel A. KIS is a protein kinase with an RNA recognition motif. J. Biol. Chem. 1997, 272:23151-23156.
27. Boehm M., Yoshimoto T., Crook M.F., Nallamshetty S., True A., Nabel G.J., Nabel E.G. A growth factor-dependent nuclear kinase phosphorylates p27(Kip1) and regulates cell cycle progression. EMBO J. 2002, 21:3390-3401.
28. Holzel M., Rohrmoser M., Orban M., Homig C., Harasim T., Malamoussi A., Gruber-Eber A., Heissmeyer V., Bornkamm G., Eick D. Rapid conditional knock-down-knock-in system for mammalian cells. Nucleic Acids Res. 2007, 35:e17.
29. Carneiro F.R., Silva T.C., Alves A.C., Haline-Vaz T., Gozzo F.C., Zanchin N.I. Spectroscopic characterization of the tumor antigen NY-REN-21 and identification of heterodimer formation with SCAND1. Biochem. Biophys. Res. Commun. 2006, 343:260-268.
30. Netzer C., Rieger L., Brero A., Zhang C.D., Hinzke M., Kohlhase J., Bohlander S.K. SALL1, the gene mutated in Townes-Brocks syndrome, encodes a transcriptional repressor which interacts with TRF1/PIN2 and localizes to pericentromeric heterochromatin. Hum. Mol. Genet. 2001, 10:3017-3024.
31. Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R., Greff Z., Keri G., Stemmann O., Mann M. Kinase-selective enrichment enables quantitative phosphoproteomics of the kinome across the cell cycle. Mol. Cell 2008, 31:438-448.
32. Chen R.Q., Yang Q.K., Lu B.W., Yi W., Cantin G., Chen Y.L., Fearns C., Yates J.R., Lee J.D. CDC25B mediates rapamycin-induced oncogenic responses in cancer cells. Cancer Res. 2009, 69:2663-2668.
33. Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P. A quantitative atlas of mitotic phosphorylation. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10762-10767.
34. Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M. Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis. Sci. Signal. 2010, 3:ra3.
35. Van Hoof D., Munoz J., Braam S.R., Pinkse M.W., Linding R., Heck A.J., Mummery C.L., Krijgsveld J. Phosphorylation dynamics during early differentiation of human embryonic stem cells. Cell Stem Cell 2009, 5:214-226.
36. Maucuer A., Le Caer J.P., Manceau V., Sobel A. Specific Ser-Pro phosphorylation by the RNA-recognition motif containing kinase KIS. Eur. J. Biochem. 2000, 267:4456-4464.
37. Denslow S.A., Wade P.A. The human Mi-2/NuRD complex and gene regulation. Oncogene 2007, 26:5433-5438.
38. Makeyev A.V., Liebhaber S.A. The poly(C)-binding proteins: a multiplicity of functions and a search for mechanisms. RNA 2002, 8:265-278.
39. Brazao T.F., Demmers J., van Ijcken W., Strouboulis J., Fornerod M., Romao L., Grosveld F.G. A new function of ROD1 in nonsense-mediated mRNA decay. FEBS Lett. 2012, 586:1101-1110.
40. Bieche I., Manceau V., Curmi P.A., Laurendeau I., Lachkar S., Leroy K., Vidaud D., Sobel A., Maucuer A. Quantitative RT-PCR reveals a ubiquitous but preferentially neural expression of the KIS gene in rat and human. Brain Res. Mol. Brain Res. 2003, 114:55-64.
41. Cambray S., Pedraza N., Rafel M., Gari E., Aldea M., Gallego C. Protein kinase KIS localizes to RNA granules and enhances local translation. Mol. Cell. Biol. 2009, 29:726-735.
42. Maucuer A., Camonis J.H., Sobel A. Stathmin interaction with a putative kinase and coiled-coil-forming protein domains. Proc. Natl. Acad. Sci. U. S. A. 1995, 92:3100-3104.
43. Spielhaupter C., Schatzl H.M. PrPC directly interacts with proteins involved in signaling pathways. J. Biol. Chem. 2001, 276:44604-44612.